Imuracetam

Imuracetam

Names
Preferred IUPAC name N,N′-Bis[(2-oxopyrrolidin-1-yl)methyl]urea
Other names UCB-G218
Identifiers
CAS Number	67542-41-0  Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL2106342
ChemSpider	143327  Y
PubChem CID	163319
UNII	972FNV35ZM  Y
CompTox Dashboard (EPA)	DTXSID20217875
InChI InChI=1S/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18) Y Key: WMKONRFEZGAHTE-UHFFFAOYSA-N Y InChI=1/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18) Key: WMKONRFEZGAHTE-UHFFFAOYAT
SMILES O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2
Properties
Chemical formula	C11H18N4O3
Molar mass	254.290 g·mol−1
Melting point	184.5 °C (364.1 °F; 457.6 K) [1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Y  verify  (what is  YN ?) Infobox references

Imuracetam (INN Tooltip International Nonproprietary Name; developmental code name UCB-G218) is a drug of the racetam group described as a nootropic (cognitive enhancer). ^{[2] [3]} It was under development in the 1970s but was never marketed. ^[1]

References

1. Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 3. CRC Press.
2. Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 681. ISBN   978-1-4757-2085-3 . Retrieved 1 October 2024.
3. Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG (February 1998). "Synthesis and psychotropic activity of new 2-pyrrolidone derivatives". Pharmaceutical Chemistry Journal. 32 (2): 55–58. doi:10.1007/BF02464161. S2CID   29810469.